FIELD: medicine. SUBSTANCE: preparation contains effective quantity of or molecules of antibody bindable on WFGNRWHEGYR amino acid sequence as active ingredient. Method involves administering the preparation for treating the cases of flat cell cancer. EFFECT: enhanced effectiveness of treatment. 8 cl, 5 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY VFF-18 AND ITS ANALOGUES | 1995 |
|
RU2204606C2 |
| ISOLATED NUCLEIC ACID ENCODING POLYPEPTIDE TAG 7, ISOLATED POLYPEPTIDE TAG 7, METHOD FOR INHIBITION OF TUMOR DEVELOPMENT IN MAMMALS (VARIANTS) AND METHOD FOR TREATMENT OF CANCER IN ANIMAL (VARIANTS) | 1998 |
|
RU2238976C2 |
| IMMUNOSTIMULATOR INDUCING TUMOR-SPECIFIC IMMUNE CELLULAR RESPONSE AND METHOD FOR ITS PREPARING | 1996 |
|
RU2206329C2 |
| MONOCLONAL ANTIBODIES TO CD44, INTENDED FOR USE IN TREATING SQUAMOUS CELL CARCINOMA OF THE HEAD AND THE NECK | 2011 |
|
RU2599447C2 |
| METHOD OF TREATING CANCER CARRYING EGFR MUTATIONS | 2007 |
|
RU2492864C2 |
| MONOCLONAL ANTIBODIES BINDING WITH hGM-CSF AND COMPOSITIONS FOR MEDICINAL PURPOSES, CONTAINING THEREOF | 2008 |
|
RU2517596C2 |
| ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER DIAGNOSIS | 2013 |
|
RU2661772C2 |
| ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6 | 2012 |
|
RU2676731C2 |
| ANTIBODIES FOR TREATING CANCER, IN WHICH CLAUDIN 6 IS EXPRESSED | 2012 |
|
RU2816850C2 |
| MULTI-SPECIFIC ANTIBODIES INTENDED FOR USE IN TREATMENT OF URINARY TRACT NEOPLASM | 2017 |
|
RU2766358C2 |
